A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis

INTRODUCTION: Natalizumab is a new humanized monoclonal antibody used in multiple sclerosis (MS). The aim of this meta-analysis was to evaluate the efficacy and tolerability of this drug in relapsing MS. PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nikfar, Shekoufeh, Rahimi, Roja, Rezaie, Ali, Abdollahi, Mohammad
Formato: Artigo
Lenguaje:Inglês
Publicado: Termedia Publishing House 2010
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3281346/
https://ncbi.nlm.nih.gov/pubmed/22371753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2010.13901
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares